332 related articles for article (PubMed ID: 9670967)
21. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
22. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection.
Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG
Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405
[TBL] [Abstract][Full Text] [Related]
23. Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator.
Nakamura Y; Yasunami Y; Satoh M; Hirakawa E; Katsuta H; Ono J; Kamada M; Todo S; Nakayama T; Taniguchi M; Ikeda S
Transplantation; 2003 Apr; 75(8):1115-8. PubMed ID: 12717187
[TBL] [Abstract][Full Text] [Related]
24. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.
Itoh S; Kimura N; Axtell RC; Velotta JB; Gong Y; Wang X; Kajiwara N; Nambu A; Shimura E; Adachi H; Iwakura Y; Saito H; Okumura K; Sudo K; Steinman L; Robbins RC; Nakae S; Fischbein MP
Circulation; 2011 Sep; 124(11 Suppl):S187-96. PubMed ID: 21911812
[TBL] [Abstract][Full Text] [Related]
26. The role of cytotoxic T lymphocytes in corneal allograft rejection.
Hegde S; Niederkorn JY
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
[TBL] [Abstract][Full Text] [Related]
27. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
28. Islet allograft rejection in sensitized mice is refractory to control by combination therapy of immune-modulating agents.
Hong J; Yeom HJ; Lee E; Han KH; Koo TY; Cho B; Ro H; Oh KH; Ahn C; Yang J
Transpl Immunol; 2013 Mar; 28(2-3):86-92. PubMed ID: 23357716
[TBL] [Abstract][Full Text] [Related]
29. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts.
Poulin LF; Richard M; Le Moine A; Kiss R; McKenzie AN; Goldman M; Renauld JC; Van Snick J; Braun MY
Transplantation; 2003 Aug; 76(3):572-7. PubMed ID: 12923446
[TBL] [Abstract][Full Text] [Related]
31. IL-2 and IL-4 double knock-out mice reject islet allografts: a role for novel T-cell growth factors?
Roy-Chaudhury P; Manfro RC; Steiger J; Nickerson PW; Tian Y; Zheng XX; Li YS; Strom TB
Transplant Proc; 1997; 29(1-2):1083-4. PubMed ID: 9123210
[No Abstract] [Full Text] [Related]
32. Cardiac allografts from IL-4 knockout recipients: assessment of transplant arteriosclerosis and peripheral tolerance.
Mottram PL; Räisänen-Sokolowski A; Glysing-Jensen T; Stein-Oakley AN; Russell ME
J Immunol; 1998 Jul; 161(2):602-9. PubMed ID: 9670933
[TBL] [Abstract][Full Text] [Related]
33. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts.
Diamond AS; Gill RG
J Immunol; 2000 Jul; 165(1):247-55. PubMed ID: 10861058
[TBL] [Abstract][Full Text] [Related]
34. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
35. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
Isakov N; Bach FH
J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
[TBL] [Abstract][Full Text] [Related]
36. Sequential analysis by polymerase chain reaction of mononuclear leukocyte activation-associated transcription in pancreatic islet cell allograft rejection.
O'Connell PJ; Pacheco-Silva A; Bastos M; Xu HW; Pankewycz O; Rubin-Kelley VE; Strom TB
Transplant Proc; 1991 Feb; 23(1 Pt 1):811-2. PubMed ID: 1990697
[No Abstract] [Full Text] [Related]
37. Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival.
Li XC; Ima A; Li Y; Zheng XX; Malek TR; Strom TB
J Immunol; 2000 Feb; 164(3):1193-9. PubMed ID: 10640730
[TBL] [Abstract][Full Text] [Related]
38. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.
Simeonovic CJ; Townsend MJ; Karupiah G; Wilson JD; Zarb JC; Mann DA; Young IG
Cell Transplant; 1999; 8(4):365-73. PubMed ID: 10478716
[TBL] [Abstract][Full Text] [Related]
40. Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
Heidecke CD; Kupiec-Weglinski JW; Lear PA; Abbud-Filho M; Araujo JL; Araneda D; Strom TB; Tilney NL
J Immunol; 1984 Aug; 133(2):582-8. PubMed ID: 6234351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
